Memory and cognition decline are typical hallmarks of neurodegenerative diseases like Alzheimer’s. While current treatments often focus on addressing symptoms, […]
Unlocking Cognitive Benefits Through Cannabinoid Receptors and Choline-Containing Lipids Read Post »
The increasing prevalence of neurodegenerative diseases like Alzheimer’s, Parkinson’s, and Huntington’s diseases necessitates innovative therapeutic strategies. A recent review from
Shp2 – A Promising Target for Neurodegenerative Disease Therapies Read Post »
Huntington’s disease (HD) is a devastating neurodegenerative disorder characterised by motor, cognitive, and psychiatric symptoms. Despite being linked to a
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that affects millions worldwide. A key hallmark of the disease is the
Microglia Depletion and Its Neuroprotective Role in Parkinson’s Disease Read Post »
Astrocytes, a key type of glial cell in the brain, have long been recognised for their supportive role in maintaining
Modulating Astrocytes With Rapamycin to Tackle Neurodegeneration Read Post »
Alzheimer’s disease (AD) is widely recognised for its defining features: amyloid-beta plaques and tangles of hyperphosphorylated tau protein (p-tau). But
The Complex Role of Herpesviruses in Increasing Alzheimer’s Disease Risk Read Post »
Protein misfolding and aggregation are hallmarks of neurodegenerative diseases like prion disorders, Alzheimer’s, and Parkinson’s. The mechanisms that drive these
Membrane Anchors and Their Role in Preventing Neurotoxic Protein Aggregation Read Post »